These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 38654609)
1. Tannic acid-poloxamer self-assembled nanoparticles for advanced atherosclerosis therapy by regulation of macrophage polarization. Wu H; Sheng J; Wang Z; Zu Z; Xiang K; Qi J; Wang Z; Lu G; Zhang L J Mater Chem B; 2024 May; 12(19):4708-4716. PubMed ID: 38654609 [TBL] [Abstract][Full Text] [Related]
2. Convallatoxin Promotes M2 Macrophage Polarization to Attenuate Atherosclerosis Through PPARγ-Integrin α Zhang Y; Shi X; Han J; Peng W; Fang Z; Zhou Y; Xu X; Lin J; Xiao F; Zhao L; Lin Y Drug Des Devel Ther; 2021; 15():803-812. PubMed ID: 33654384 [TBL] [Abstract][Full Text] [Related]
3. Ultrasmall Fe(III)-Tannic Acid Nanoparticles To Prevent Progression of Atherosclerotic Plaques. Mu D; Wang W; Li J; Lv P; Liu R; Tan Y; Zhong C; Qi Y; Sun X; Liu Y; Shen S; Li Y; Xu B; Zhang B ACS Appl Mater Interfaces; 2021 Jul; 13(29):33915-33925. PubMed ID: 34279905 [TBL] [Abstract][Full Text] [Related]
4. Targeted Therapy of Atherosclerosis by a Broad-Spectrum Reactive Oxygen Species Scavenging Nanoparticle with Intrinsic Anti-inflammatory Activity. Wang Y; Li L; Zhao W; Dou Y; An H; Tao H; Xu X; Jia Y; Lu S; Zhang J; Hu H ACS Nano; 2018 Sep; 12(9):8943-8960. PubMed ID: 30114351 [TBL] [Abstract][Full Text] [Related]
5. Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis. Dou Y; Chen Y; Zhang X; Xu X; Chen Y; Guo J; Zhang D; Wang R; Li X; Zhang J Biomaterials; 2017 Oct; 143():93-108. PubMed ID: 28778000 [TBL] [Abstract][Full Text] [Related]
6. STAT6 Upregulation Promotes M2 Macrophage Polarization to Suppress Atherosclerosis. Gong M; Zhuo X; Ma A Med Sci Monit Basic Res; 2017 Jun; 23():240-249. PubMed ID: 28615615 [TBL] [Abstract][Full Text] [Related]
7. Tannic acid/Mg He M; Gao X; Fan Y; Xie L; Yang M; Tian W J Mater Chem B; 2021 Jan; 9(4):1096-1106. PubMed ID: 33427278 [TBL] [Abstract][Full Text] [Related]
8. Biomimetic Platelet-Cloaked Nanoparticles for the Delivery of Anti-Inflammatory Curcumin in the Treatment of Atherosclerosis. Fontana F; Molinaro G; Moroni S; Pallozzi G; Ferreira MPA; Tello RP; Elbadri K; Torrieri G; Correia A; Kemell M; Casettari L; Celia C; Santos HA Adv Healthc Mater; 2024 Jun; 13(15):e2302074. PubMed ID: 38499190 [TBL] [Abstract][Full Text] [Related]
9. Macrophage Membrane-Encapsulated Dopamine-Modified Poly Cyclodextrin Multifunctional Biomimetic Nanoparticles for Atherosclerosis Therapy. Zhu L; Zhong Y; Yan M; Ni S; Zhao X; Wu S; Wang G; Zhang K; Chi Q; Qin X; Li C; Huang X; Wu W ACS Appl Mater Interfaces; 2024 Jun; 16(25):32027-32044. PubMed ID: 38867426 [TBL] [Abstract][Full Text] [Related]
10. CD137 signaling induces macrophage M2 polarization in atherosclerosis through STAT6/PPARδ pathway. Geng T; Yan Y; Xu L; Cao M; Xu Y; Pu J; Yan JC Cell Signal; 2020 Aug; 72():109628. PubMed ID: 32247042 [TBL] [Abstract][Full Text] [Related]
11. Gliclazide alters macrophages polarization state in diabetic atherosclerosis in vitro via blocking AGE-RAGE/TLR4-reactive oxygen species-activated NF-kβ nexus. Jahan H; Choudhary MI Eur J Pharmacol; 2021 Mar; 894():173874. PubMed ID: 33460615 [TBL] [Abstract][Full Text] [Related]
12. Biomimetic-Coated Nanoplatform with Lipid-Specific Imaging and ROS Responsiveness for Atherosclerosis-Targeted Theranostics. Ma B; Xu H; Wang Y; Yang L; Zhuang W; Li G; Wang Y ACS Appl Mater Interfaces; 2021 Aug; 13(30):35410-35421. PubMed ID: 34286950 [TBL] [Abstract][Full Text] [Related]
13. Kallistatin Inhibits Atherosclerotic Inflammation by Regulating Macrophage Polarization. Li B; Sheng Z; Liu C; Qian L; Wu Y; Wu Y; Ma G; Yao Y Hum Gene Ther; 2019 Mar; 30(3):339-351. PubMed ID: 30205711 [TBL] [Abstract][Full Text] [Related]
14. Pseudolaric acid B attenuates atherosclerosis progression and inflammation by suppressing PPARγ-mediated NF-κB activation. Li T; Wang W; Li YX; Li X; Ji WJ; Ma YQ; Chen H; Zhao JH; Zhou X Int Immunopharmacol; 2018 Jun; 59():76-85. PubMed ID: 29631101 [TBL] [Abstract][Full Text] [Related]
15. Modulating Lipoprotein Transcellular Transport and Atherosclerotic Plaque Formation in ApoE Di Francesco V; Gurgone D; Palomba R; Ferreira MFMM; Catelani T; Cervadoro A; Maffia P; Decuzzi P ACS Appl Mater Interfaces; 2020 Aug; 12(34):37943-37956. PubMed ID: 32805983 [TBL] [Abstract][Full Text] [Related]
16. Role of KCa3.1 Channels in Macrophage Polarization and Its Relevance in Atherosclerotic Plaque Instability. Xu R; Li C; Wu Y; Shen L; Ma J; Qian J; Ge J Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):226-236. PubMed ID: 28062499 [TBL] [Abstract][Full Text] [Related]
17. Reactive oxygen species scavenging and inflammation mitigation enabled by biomimetic prussian blue analogues boycott atherosclerosis. Zhang Y; Yin Y; Zhang W; Li H; Wang T; Yin H; Sun L; Su C; Zhang K; Xu H J Nanobiotechnology; 2021 May; 19(1):161. PubMed ID: 34059078 [TBL] [Abstract][Full Text] [Related]
18. Multiple pathway assessment to predict anti-atherogenic efficacy of drugs targeting macrophages in atherosclerotic plaques. Alaarg A; Zheng KH; van der Valk FM; da Silva AE; Versloot M; van Ufford LC; Schulte DM; Storm G; Metselaar JM; Stroes ES; Hamers AA Vascul Pharmacol; 2016 Jul; 82():51-9. PubMed ID: 27189780 [TBL] [Abstract][Full Text] [Related]
19. IgE Contributes to Atherosclerosis and Obesity by Affecting Macrophage Polarization, Macrophage Protein Network, and Foam Cell Formation. Zhang X; Li J; Luo S; Wang M; Huang Q; Deng Z; de Febbo C; Daoui A; Liew PX; Sukhova GK; Metso J; Jauhiainen M; Shi GP; Guo J Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):597-610. PubMed ID: 31996021 [TBL] [Abstract][Full Text] [Related]
20. Theranostics of atherosclerosis by the indole molecule-templated self-assembly of probucol nanoparticles. Chen F; Chen J; Han C; Yang Z; Deng T; Zhao Y; Zheng T; Gan X; Yu C J Mater Chem B; 2021 May; 9(20):4134-4142. PubMed ID: 33972981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]